Mary Washington Healthcare A-/A3 investment grade — Virginia regional nonprofit health system. 2 hospitals, 50+ care sites in Fredericksburg I-95 growth corridor. 5.50–6.50% NNN cap rates. Q1 2026.

Heartland Dental B-/Caa1 KKR PE-backed — largest US DSO, 1,700+ dental offices in 38 states. 7.50–9.00% NNN cap rates, $1.5M–$3.5M price range. Q1 2026.

HCA Healthcare BBB-/Ba1 split-rated — largest US for-profit hospital system, ~188 hospitals, $70B revenue. 5.50–6.50% NNN cap rates, $4M–$15M+ price range. Q1 2026.

Henry Ford Health A/A2 investment grade — major Michigan nonprofit health system, 110-year history. 6 hospitals, 250+ care sites in Southeast Michigan. 5.25–6.25% NNN cap rates. Q1 2026.

Grifols BB/Ba3 Negative — Spanish biopharmaceuticals, operates BioMat USA plasma centers. 300+ US locations. 7.00–8.50% NNN cap rates, $2.5M–$6.5M price range. Q1 2026.

EyeCare Partners CCC+/Caa2 PE-backed vision care DSO. 750+ US optometry clinics. 7.50–9.00% NNN cap rates, $1.5M–$3.5M price range. Warburg Pincus 2023 recapitalization. Q1 2026.

CSL Plasma backed by CSL Behring A-/A3 investment grade — highest-rated plasma collection NNN tenant. 300+ US centers. 5.25–6.25% NNN cap rates, $3M–$7.5M price range. Q1 2026.

Corewell Health A+/Aa3 investment grade — Michigan’s largest health system, formed by Beaumont + Spectrum Health merger. 22 hospitals, 300+ outpatient locations. 5.00–6.00% NNN cap rates. Q1 2026.

Concentra Urgent Care backed by Humana BBB+/Baa3 investment grade. 559 US centers, $1.9B revenue, largest US occupational health network. 5.50–6.50% NNN cap rates, $2M–$5M price range. Q1 2026.

BioLife Plasma Services backed by Takeda Pharmaceutical BBB-/Baa3 investment grade. ~180+ US plasma centers. 5.75–6.75% NNN cap rates, $3M–$7M price range. Q1 2026 investor guide.